Benzinga's Volume Movers
February 26, 2014 at 10:37 AM EST
Anika Therapeutics (NASDAQ: ANIK ) shares moved up 47.06% to $50.69. The volume of Anika Therapeutics shares traded was 2952% higher than normal. Anika received marketing approval for MONOVISC® from the FDA. ExamWorks Group (NYSE: EXAM ) shares rose 15.41% to $35.32. The volume of ExamWorks shares traded was
